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                       REVIEW OF LITERATURE 
Introduction  
             The unique vulnerability of the kidneys in pregnancy was first noted 
in 1843 when John Lever recognized that proteinuria occurring in 
association with maternal convulsions was an entity separate from chronic 
kidney disease. Lever’s observation came 16 years after Richard Bright’s 
recognition of proteinuria as a marker for kidney disease1. The distinction 
between primary kidney disease and preeclampsia remains one of the most 
common issues addressed by nephrologists seeing pregnant women. 
 Pregnancy in a woman with kidney disease or the development of 
primary kidney disease in a pregnant woman has long been recognized as 
dangerous. In 1936, Dieckman2 recommended termination of pregnancy if 
nephrosis occurred before 30 weeks gestation. At that time, not only was 
there no effective treatment for kidney failure, but antibiotics, steroids, and 
effective antihypertensive treatment were not available. Women with known 
kidney disease were discouraged from becoming pregnant, and most of our 
knowledge about pregnancy in kidney disease has been acquired only 
because women wanted children ignored the advice of their physicians. 
                 In 1970 Lindheimer and Katz3 observed that successful pregnancy 
was the rule in women with kidney disease whose kidney function was well 
preserved. Some investigators associated poor outcomes with specific 
glomerular lesions4, and only later did it become clear that preconception 
serum creatinine was more important than the specific kidney disease 
(except in case of lupus nephritis). Until the 1980, most series of pregnancy 
in women with kidney disease included only a few women with serum 
creatinine greater than 1.4 mg/dl. Over the following 10 years, more than 7 
reports were published detailing 226 pregnancies in 196 women with 
moderate to severe preexisting kidney disease. Collective experience 
indicated that these women risked more rapid progression to kidney failure if 
they became pregnant5-11. At the same time, advances in the care of 
premature newborns resulted in the survival of more than 90% of infants 
from pregnancies in this group of women. 
 
 
 
 
 
 
  Fertility in women with chronic kidney disease is generally reduced, 
in part because of gonadal dysfunction and secondary amenorrhea12-14. There 
may be continuum of decreased fertility as the glomerular filtration rate 
declines, but further study in this area is needed15. When counseling women 
with chronic kidney disease about pregnancy, it must be clear that 
information on outcomes is limited. In part, this is because of lack of 
systemic data, inability to randomize patients, and difficulty to find 
appropriate controls15, 16. For most patients with a serum creatinine < 1.4 
mg/dl, pregnancy leads to successful obstetrical outcome without affecting 
the course of the maternal kidney disease17-20. For patients with moderate 
renal impairment, the outlook is not optimistic; in patients with a serum 
creatinine > 2.0 gm/dl at the time of conception, one third progress to end 
stage renal disease (ESRD) over the postpartum year of follow up21. 
 
A history of dismal pregnancy outcomes in women with kidney 
disease has been observed since the 1960s22, 23. Although outcomes have 
improved with advancements in disease management, the presence of kidney 
disease during pregnancy still portends adverse outcomes for both mother 
and fetus24, 25. Beyond its association co morbid complications such as 
hypertension, chronic kidney disease is an independent risk factor for 
prematurity, low birth weight, neonatal death and preeclampsia24-26. Chronic 
kidney disease may increase the risk of such pregnancy complications by as 
much as 8-fold24, 25. Hence the coexistence of chronic kidney disease and 
pregnancy remains a daunting clinical scenario for both health care 
providers and patients. 
 Acute renal failure has become a rare complication of pregnancy due 
to the virtual disappearance of septic abortion and vigilant antenatal care in 
the western countries. In the 1960s pregnancy-related represented 20-40 
percent of all cases of ARF, but the incidence have decreased dramatically 
there after. In the 1980s the estimated incidence if ARF requiring dialysis 
during pregnancy in the western countries was less than .01 percent. In 
contrast, obstetric ARF still remains a serious problem in developing 
countries; it constitutes 15-25 percent of all cases of ARF referred to dialysis 
centers in India. 
 
 
 
 
 
   However, in some parts of India, the incidence of obstetric ARF has 
shown a decline from 22 percent [of all ARF] in 1960s to 8 percent in 1990s. 
In Ethiopia, septic abortion is the underlying cause of ARF in 52 percent of 
all patients with ARF. In Argentina and Nigeria obstetric complications still 
account for 32 percent and 25 percent of cases of ARF, respectively. 
Obstetric ARF has a bimodal occurrence in developing countries. The first 
peak is seen between 8 and 16 weeks of gestation in association with septic 
abortions; whereas late peak is seen after 34 weeks associated with 
eclampsia, abruption-placentae, post-partum hemorrhage and puerperal 
sepsis. The first peak is nearly eliminated in industrialized countries due to 
the virtual disappearance of septic abortion. 
Obstetric group 
 Based on the obstetric problems patients are divided into two groups: 
ARF in early pregnancy and ARF in late pregnancy. Acute renal failure is 
related to abortion in all cases in early pregnancy. However, ARF in late 
pregnancy develops, in association with multiple obstetric complications 
consisting of eclampsia, puerperal sepsis, uterine hemorrhage and 
postpartum hemolytic uremic syndrome.  
Probable pathogenesis 
 Multiple factors are involved in the development of obstetric ARF. 
These include hypotension, sepsis, infection and blood loss.. Sepsis is more 
frequent in patients with induced abortion than in spontaneous abortion. In 
addition, intravascular hemolysis disseminated intravascular coagulation and 
adult HUS also is causes of ARF in pregnancy. 
 
Chronic Kidney Disease and Pregnancy: Pathophysiology 
 It is well established that renal blood flow and glomerular filtration 
rate (GFR) increase substantially during pregnancy. GFR begins to rise 
within the first month after conception, increasing up to 50% by the 16th to 
18th gestational week of pregnancy.  
               This state of hyper filtration persists throughout the rest of 
pregnancy with GFR returning to baseline values 3 months postpartum. 
Although the precise mechanisms for these changes in kidney 
hemodynamics remain unclear, a combination of increased extra cellular 
volume and cardiac output and decreased renal vascular resistance is 
involved.  
 
 
 
 
 
Some have proposed that pregnancy induced hyper filtration may lead 
to acceleration of GFR decline in chronic kidney disease. However, hyper 
filtration in pregnancy appears to be caused primarily by increases in renal 
blood flow rather than increases in intra glomerular pressure so it is less 
likely to lead to pathological sequelae. In fact, animal models have not 
shown glomerulosclerosis after repeated gestations. Moreover, women with 
preexisting kidney disease, who are most likely to have a pregnancy 
associated GFR decline, often do not appear to acquire a hyper filtered state 
during pregnancy. 
 Closely related to this phenomenon of hyperfiltration is the 
hypervolemic state that exists during pregnancy. Substantial weight gain 
occurs during pregnancy with much of the weight gain resulting from 
sodium and fluid retention. The extra cellular fluid space often expands by 
7L. The reasons for this volume expanded state are not entirely clear. 
“Under fill”, “overfill” and “normal fill” concepts invoking various 
hormonal changes have been hypothesized, and all may be at work in 
different stages of pregnancy. In addition to its influence on renal blood flow 
and GFR, this hypervolemic state also carries implications toward 
hypertension and its management during pregnancy. 
 A few other important factors influencing the effect of pregnancy on 
kidney function are  
           1) Increase in urinary protein and albumin excretion occurs 
commonly during pregnancy, often achieving microalbuminuria levels but 
generally staying below 500mg/d. The mechanism for this is not well 
understood, but alteration of GFR and tubular reabsorption are thought to 
contribute. Unfortunately the exact nature of these changes and their 
prognostic significance are not well studied. Prolonged recurrent periods of 
elevated proteinuria theoretically could lead to kidney damage and 
progressive kidney disease. 
            
 
 
 
 
 
 
 
 
 
 
 2) Pregnancy is associated with a relative hypercoagulable state. 
Several components of the coagulation cascade are increased, and 
fibrinolytic activity is decreased during pregnancy. These changes could 
mediate insidious thrombotic glomerular injury, especially with recurrent 
pregnancies. 
  3) The frequent development of hypertension in pregnancy 
complicated by preexisting kidney disease also may play a substantial role in 
deterioration of kidney function. However data are lacking regarding the 
precise burden imposed by gestational hypertension.           
  
  
Prevalence and epidemiology of chronic kidney disease during 
pregnancy 
Chronic kidney disease usually results from cumulative organ injury 
over an extended period of time. Therefore, it is not surprising that the 
presence of chronic kidney disease in pregnant women is rather uncommon 
because the pregnant population is usually young and relatively healthy. 
Two retrospective studies have characterized the prevalence of chronic 
kidney disease in pregnant population. Fink et al noted the incidence of 
kidney disease to be 0.03% among pregnant women in the state of 
Washington from 1987 – 1993. In two other reviews of kidney disease in 
pregnant women during 1990’s from Colorado and Japan the prevalence of 
kidney disease was higher but still not excessive at 0.1% to 0.12%. it is 
important to realize that these findings are likely under estimates for several 
reasons.  
 
       It has become increasingly apparent that chronic kidney disease is under 
recognized by health care providers and hence under documented in 
patients’ record. This under recognition is likely further embellished during 
pregnancy when one considers the physiological changes that normally 
occur with pregnancy. A customary increase in maternal renal plasma flow 
and GFR occur during pregnancy. Consequently a pregnant woman serum 
creatinine generally decreases by 0.4 mg/dl during pregnancy and the normal 
value is usually around 0.5 mg/dl. 
 
 
 
 
 
 
 
 
In fact the serum creatinine exceeding 0.8mg/dl is generally 
considered to be abnormally elevated. Thus chronic kidney disease is likely 
to be unrecognized during pregnancy. Second, it is known that pregnancy 
losses are more likely in the setting of chronic kidney disease and its 
associated co morbid conditions. Early pregnancy losses may not be always 
noted by the mother or captured by studies. These factors suggest that the 
occurrences of pregnancy in woman with chronic kidney disease as well as 
the presence of chronic kidney disease in pregnant woman are under 
estimated. 
   A broader estimate of the prevalence of chronic kidney disease can 
be viewed from the frequency of kidney disease in women of child bearing 
age. Based on data gathered by Nissenson et al from a large health 
maintenance organization in the south western United States during 1994 to 
1997, it appears that up to 4% of child bearing – aged women ( up to 49 
years old ) have chronic kidney disease (defined by a serum creatinine 
greater than or equal to 1.2 mg/dl). Because a number of women may have 
substantial decreases in GFR at creatinine lower than 1.2mg/dl or have 
kidney disease manifested in ways other than substantial GFR decline, it is 
likely that chronic kidney disease is present in an even larger percentage of 
child bearing – aged women. 
 A number of types of chronic kidney disease will be found in a setting 
of pregnancy, including diabetic nephropathy, chronic glomerulonephritis, 
reflux nephropathy, tubulointerstitial disease, systemic lupus erythematosis, 
and polycystic kidney disease. Diabetic nephropathy is generally the most 
common form of chronic kidney disease during pregnancy. 
                 Because most studies of kidney disease are retrospective analysis 
relying on administrative data or case series, a precise characterization of the 
frequency of different kidney disease in the setting is challenging and 
compromised by a lack of detail and specificity. Nonetheless, the largest and 
broadest description of etiology of chronic kidney disease in pregnancy is 
provided in the study by Fink et al. 
 
 
 
 
 
 
 
 
 
 In their analysis, the following causes of chronic kidney disease were 
observed: diabetic nephropathy (7%), chronic glomerulonephritis (8%), 
unspecified nephritis or nephropathy (11%), chronic renal failure (7%), 
nephritic syndrome (13%), renal agenesis (14%), and cystic diseases of the 
kidney excluding acquired cystic disease (18%).based on these data and 
others, it is important to recognize that significant heterogeneity exists 
among the causes of chronic kidney disease in pregnant women. 
Pregnancy outcomes and chronic kidney disease 
 A number of small studies have evaluated pregnancy outcomes in the 
setting of maternal kidney disease. In reviewing this subject, it is important 
to distinguish between primary kidney disease and systemic diseases possess 
additional specific features beyond nephropathy that contribute to maternal 
and fetal outcomes.  
 It is critical to recognize the limitation of the published analyses. First, 
most of these studies consist of small sample sizes at single centers, 
compromising the generalizability of the conclusions. Second, the vast 
majority of these studies are retrospective in design, subjecting their findings 
to bias and confounding. Third, few these studies involved the comparison 
groups of healthy women without kidney disease are invoked multivariable 
analysis statistical methods. Thus, attributing the nature and extent of 
suboptimal maternal and fetal outcomes to kidney disease on the basis of 
published literature is difficult. Moreover, a variety of definitions for kidney 
disease were used by the authors, limiting comparisons between the 
published studies. In addition, the definition of important maternal and fetal 
outcome measures often differed between studies. In particular, the nature, 
reversibility and acceleration of kidney function (GFR) decline and the 
persistence of changes in hypertension and proteinuria have had varying 
meanings and occasionally were not clarified by the authors. Nonetheless, 
the existing literature is helpful in understanding the relationship between 
chronic kidney disease and pregnancy and the underscores the importance of 
maternal kidney function at consumption on pregnancy outcomes. 
 
 
 
 
 
 
 
 
 
Primary kidney disease and pregnancy outcomes 
 Mild kidney disease (maternal serum creatinine < 1.3 mg/dL) 
 Maternal outcomes: Pregnancy in the setting of mild maternal kidney 
disease does not precipitate an accelerated worsening of maternal kidney 
function. However, the development or worsening of hypertension, 
proteinuria, and preeclampsia occurs in as many as one third of pregnant 
women with mild kidney disease. The long-term implications of these events 
have not been well evaluated in this population. 
               Early studies raised the concern that maternal kidney function 
could undergo irreversible deterioration during a normal gestation. Four 
studies of roughly 600 pregnancies in women with the serum creatinine < 
1.3 mg/dl did not observe any accelerated decline in maternal GFR during 
pregnancy. A review by Imbasciati and Ponticelli summarized the result of 6 
large studies of pregnancy and kidney diseases during the last 25 years. 
Collectively, 906 pregnancies in 558 women with histologically defined 
primary kidney disease were included. Over 95% of the subjects had a serum 
creatinine <1.5 mg/dl. Over all, by the end of gestation, kidney function 
showed a reversible decline in 8% of women but a progressive decline in 
only 3%. 
 More recent studies from the 1990s also deserve mention in an 
observational trail, Abe compared 32 pregnant women with biopsy proven 
ImmunoglobulinA (IgA) nephropathy with 30 women with IgA nephropathy 
who did not conceive over a 5-year period, the initial and final GFR 
measurements did not vary significantly between the 2 groups. Jungers et al 
studied the incidence of n stage renal disease over 30 years of follow up in 
320 women with various glomerular diseases and mildly abnormal kidney 
function. Kidney survival did not differ significantly between the group of 
women who became pregnant and who did not. More over, in multi variable 
analysis, pregnancy was found to be a risk factor for end stage real disease. 
 
 
 
 
 
 
 
 
 
 
 
 
Fetal outcomes 
 Prematurity, low birth weight and fetal death are slightly higher in the 
setting of mild maternal primary chronic kidney disease. However, it does 
appear that these negative outcomes have dissipated over time with advances 
in medical care. Unfortunately, the independent roles of proteinuria and 
hypertension are not well distinguished. The aforementioned review by 
Imbasciati and Ponticelli addresses the typical fetal outcomes associated 
with mild maternal kidney disease. In these studies the overall rate for fetal 
loss was 21%; preterm delivery was also high at 19%. Importantly this 
article incorporated data from 1980s. A more recent analysis by Bar et al 
suggests that fetal outcomes in the presence of mild chronic kidney disease 
have improved over time; in this study successful fetal outcome was 
reported in 98% of patients. About 65% of pregnancies resulted in no 
obstetrical or fetal complication such as preeclampsia, intrauterine growth 
retardation, or preterm delivery. Similar findings were found in Chapman et 
al who found no difference in fetal outcomes between women with and 
without autosomal dominant polycystic kidney disease. In contrast in a 
prospective matched control study by Holley et al, pregnancy losses were 
found to be higher in women with chronic kidney disease (32%) compared 
with controls (7%), regardless of the presence of hypertension. One 
explanation for these findings may be the more sensitive detection of early 
pregnancy losses with this study design and the inclusion of high proportion 
of women with non primary kidney disease such as diabetic nephropathy and 
lupus nephropathy. 
                Clearly, although improvements have occurred, some degree of 
fetal compromise in the setting of mild maternal kidney disease continues to 
exist as represented by higher rates of preterm delivery, low birth weight, 
and fetal loss compared with normal controls. 
 
 
 
 
 
 
 
 
 
 
 
 
Moderate kidney disease (Maternal Serum Creatinine 1.3 to 1.9 mg/dl) 
Maternal outcomes 
 A decline in maternal kidney function during pregnancy is more 
common in the setting of moderate maternal kidney disease. On average, one 
fifth to one third of such women may have an accelerated decline in GFR as 
shown in regression analysis by Jungers et al. Furthermore hypertension and 
proteinuria were more common, more often worsen, and strongly associated 
with decline in kidney function. A study by Jones and Hayslett sheds some 
insight into the impact of pregnancy on maternal kidney function in 
moderate kidney disease at conception. Overall the mean serum creatinine 
increased from 1.9 mg/dl to 2.5 mg/dl over the course of pregnancy or up to 
6 weeks postpartum (P<.001). A pregnancy related loss of kidney function 
occurred in 50% women. Furthermore, this decline in kidney function 
persisted for 6 months postpartum in 31% of the study population and 10% 
of the total group reached end-stage renal disease. Thus women with serum 
creatinine levels of 1.3 to 1.9 mg/dl at conception are at higher risk of 
pregnancy associated decline in kidney function. 
Fetal outcomes 
Significant fetal risks occur in the setting of moderate maternal kidney 
disease; prematurity, low birth weight, and fetal loss are more likely than 
with mild maternal chronic kidney disease, and these complications often 
exceed 50%. In the review by Jones and Hayslett both preterm delivery 
(55% compared with the average rates of 10%) and fetal mortality (6% 
increases) were higher. Mean fetal birth weight was reduced, and 37% of 
infants were below the tenth percentile for birth weight. These observations 
have also been noted in other contemporary studies. Imbasciati ant Ponticelli 
found preterm delivery occurring in 50% of pregnancies to mothers with 
moderate kidney disease; 34% of infants were for small for gestational age. 
Although fetal compromise is often present, most infants born in these 
setting do survive. 
 
 
 
 
 
 
 
 
 
Severe kidney Disease (Maternal Serum Creatinine >1.9 mg/dl) 
Maternal Outcomes:  
 A paucity of observations exists to characterize the effect of 
pregnancy on maternal outcomes in women with more severe kidney disease 
at conception. Nonetheless, it does appear that significant declines in 
maternal kidney function more consistently occur in this setting than in 
milder forms of disease and that hypertension and proteinuria are more 
frequent. Imbasciati et al noted accelerated decline in kidney function 
occurred in over 25 % of women with severe kidney disease at conception.  
                In the analysis of Jones and Hayslett, similar reductions in GFR 
were seen in the moderate and severe kidney disease sub groups. However, 
it was clearly noted that the risk of GFR decline was highest when maternal 
serum creatinine >2mg/dl.  
Fetal outcomes 
 Because of infertility and a high rate of early pregnancy failure in 
women with a serum creatinine > 1.9 mg/ dl, little information exists 
regarding fetal outcomes in this setting. When pregnancy does occur, 
prematurity, low birth weight, and neonatal death are more the rule than the 
exception. In a comparison of moderate with severe kidney disease groups, 
adverse fetal outcomes were clearly linked to the degree of kidney functional 
impairment. With moderate kidney disease, the proportional of preterm 
delivery was 55% and intrauterine growth retardation was 31%. In the 
setting of severe kidney disease, preterm delivery occurred 73% of the time 
and intrauterine growth retardation 53% of the time. Cunningham et al noted 
that sever kidney failure correlated with adverse fetal outcomes means fetal 
birth weight was 1,520 grams in the setting of severe maternal kidney 
disease and 2,500 grams in moderate kidney disease, whereas preterm 
delivery rose from 30% in moderate maternal kidney disease to 86% in 
severe maternal kidney disease. 
 
 
 
 
 
 
 
 
 
 
 
 
Other Factors Related To Pregnancy Outcomes in Primary Maternal 
Kidney Disease 
Etiology of Maternal Primary Kidney Disease 
 Whether the etiology of maternal primary kidney disease specifically 
influences maternal and fetal outcomes has been investigated by some. The 
general consensus is that fetal outcomes are not differentially impacted by 
different classes of glomerulonephritis, assuming other important factors are 
similar. The role of kidney disease etiology on changes in maternal kidney 
function is less clear. Conflicting findings exist in regard to a pregnancy-
induced accelerated decline in maternal kidney function with 
membranoproliferative glomerulonephritis and focal segmental 
glomerulosclerosis. However, in two of the larger series of patients, Katz, et 
al and Jungers et al noted the changes in maternal GFR did not appear to 
differ between types of glomerulonephritis. Hence, although this topic has 
not been thoroughly studied, no conclusive evidence exists to suggest that 
maternal or fetal prognosis differs significantly by the underlying cause of 
kidney disease.  
Proteinuria  
 Transient increases in proteinuria are common during normal 
pregnancy and even more pronounced during pregnancy complicated by 
chronic kidney disease. Several studies found increased protein excretion in 
up to two thirds of women with chronic kidney disease, reaching nephritic 
range in up to one third of such individuals. Proteinuria not only commonly 
reflects the degree of kidney damage but also holds prognostic value for 
progression of kidney disease.  
             Several investigators have noted that subgroups of pregnant women 
with chronic kidney disease and proteinuria exceeding 1 gm/day have a 
greater tendency for accelerated GFR decline and nearly a 2- fold higher 
incidence of end- stage renal disease.  
 
 
 
 
 
 
 
 
 
 
The most thorough analysis of the role of proteinuria on maternal 
kidney disease performed by Hemmelder et al. in a retrospective analysis 
using linear regression analysis, the degree of proteinuria at conception in 
women with glomerular disease was found to be a significant independent 
risk factor for accelerated GFR decline in pregnancy. Equally important is 
the impact of proteinuria on fetal outcomes, an increase in adverse fetal 
outcome has generally been observed with increasing degrees of proteinuria, 
especially when proteinuria is within nephrotic range. Barcelo et al observed 
an inverse relationship between the degrees of proteinuria and fetal birth 
weight. Comprehensive long term studies evaluating the occurrence, 
persistence, and significance of proteinuria and microalbuminuria in this 
setting are needed. 
Hypertension 
 In pregnancies of women with kidney disease, hypertension is more 
likely to occur and preexisting hypertension often worsens. In the setting of  
mild maternal kidney disease, new onset hypertension or an exacerbation of 
existing hypertension occurred in more than 25% of pregnancies. 
Hypertension is an even more frequent occurrence in moderate and severe 
kidney disease, present in more than 50% of such pregnancies. The 
development of hypertension portends a greater likelihood of GFR 
deterioration. In the review by Imbasciati and Ponticelli, a 3-fold higher 
prevalence of hypertension was noted in the group with GFR decline during 
pregnancy. Others have found hypertension to be an independent predictor 
of maternal GFR decline 9-fold. Hypertension in pregnancies complicated 
by maternal kidney disease further aggravates fetal outcomes. Many studies 
have noted that hypertension leads to a 2 to 10- fold increase in adverse fetal 
events such as prematurity, low birth weight and death. Furthermore, the 
coexistence oh hypertension and chronic kidney disease appear to have a 
synergistic effect on poor fetal outcomes. A few studies have even found 
hypertension to be a more lethal independent risk factor for fetal 
compromise than mild chronic kidney disease. 
  
 
 
 
 
 
 
 
 
Chronic kidney disease clearly plays an important role during 
pregnancy. Because of advances in medical care, maternal and fetal 
outcomes in the setting of chronic kidney disease have greatly improved 
since the initial case series observations in Australia during the 1960s when 
fetal mortality approached 100%. The 2 most important factors affecting 
prognosis in this setting are the degree of kidney functional impairment and 
the presence of hypertension at conception. In the absence of poorly 
controlled hypertension, moderate to severe primary chronic kidney disease, 
advanced diabetic nephropathy or active lupus nephropathy, the rates of 
uncomplicated fetal outcomes are good.  
                  Furthermore, pregnancy does not appear to accelerate the loss of 
kidney function with mild disease, in part because of the lesser risk of 
hypertensive complications. As the severity of kidney function and 
hypertension at conception increase, the likelihood of unfavorable outcomes 
for both the mother and the fetus grow substantially. Truly, a compelling 
dilemma confronts women with moderate and severe kidney disease. 
Although medical care has led to improvements in fetal viability in this 
setting, a high risk of rapid maternal kidney disease progression continues to 
exist. Unfortunately, as their fertility declines with progression of their 
kidney disease over time, future opportunities for pregnancy will become 
limited. Therefore, it is critical that women of child bearing age with chronic 
kidney disease be carefully counseled about the risk of pregnancy based on 
the available epidemiologic data. 
Neonatal Mortality 
 According to the most recent national vital statistics report, the two 
leading causes of infant death in the United States are congenital 
malformations and complications of prematurity, accounting for 20% and 
175 of infant deaths, respectively. Overall infant mortality rate in the United 
States in the year 2003 was 0.68%, but the rates were much higher for 
preterm infants, especially in those born before 32 weeks of gestational age.  
 
 
 
 
 
 
 
 
 
 
Whereas mortality in full term infants (37 weeks or more) was 
0.25%, it was 0.85% in those born between 32 and 36 weeks of gestational 
age and increased considerably (18.8%) in those born at less than 32 weeks 
of gestational age. Small for gestational age (SGA) infants, defined as the 
birth weight less than the tenth percentile for gestational age, also have a 
higher mortality than an appropriately sized infant of the same gestational 
age. 
 Compared with general population babies born to mothers with CKD 
and ESRD are more likely to be born premature or SGA and are at an 
increased risk for death during the neonatal period. Information about the 
neonatal outcome of pregnancies in renal transplant recipients comes from 
National Transplantation Pregnancy Registry (NTPR), a United States – 
based registry, the European Dialysis and Transplant Association (EDTA) 
Registry, the United Kingdom Transplant Pregnancy Registry, and a few 
small case series. 
Neonatal outcome in Mothers with Chronic Kidney Disease 
Information on the pregnancy outcomes of mothers with CKD is less well 
organized than the registry data available for ESRD. The CKD information 
comes mainly from retrospective case series and collectively contains about 
1,300 pregnancies from mothers with varied etiologies and stages of CKD. 
The reported neonatal mortality in these series ranges from 3% to 12%, the 
rate of preterm births is 16% to 59%, and the incidence of SGA infants is 
7% to 37%. Similar to the ESRD data, the rate of preterm births and SGA 
births in women with CKD appears to increase with worsening maternal 
kidney function, severe proteinuria, and hypertension. 
Neonatal Morbidity 
 No detailed information is available on short term neonatal morbidity 
in infants born to mothers with CKD or ESRD, aside from the reported 
generic “newborn complication” rate of 41% to 54% in babies born to 
women with functioning kidney transplant. Despite the lack of specific 
details on neonatal morbidity associated with pregnancies complicated by 
ESRD and CKD, one can infer the potential outcomes by recognizing the 
morbidity associated with prematurity, the most common outcome of 
pregnancy associated with ESRD and CKD.  
 
 
 
 
 
 Despite the achievement of substantial improvement in neonatal care 
over the past decade, premature infants especially very low birth weight 
infants ( < 1,500 g) continue to be at a very high risk for a variety of clinical 
complications, such as pneumothorax, respiratory distress syndrome, sepsis, 
necrotizing enterocolitis, chronic lung disease, deafness and intraventricular 
hemorrhage. Fortunately the risk of extreme prematurity appears to be small 
in infants born to mothers with CKD and ESRD, significant morbidity can 
still occur in even the most mature (>2,500 g) of the premature infant 
population. 
The ability to provide an accurate assessment of neonatal outcome of 
infants born to women with CKD is made difficult by the lack of good data. 
Currently, we are aware that pregnancy in women with CKD and ESRD is 
associated with high rate of preterm birth and SGA infants with resultant 
increased risk of neonatal mortality. Whether the risks are caused by the 
specific underlying maternal kidney disease, factors unique to kidney 
transplantation or dialysis, or one of the many co morbid conditions or 
required medications is not clear and requires further investigation. 
Although an increased risk of congenital anomalies does not appear to occur 
in this population, the information should be viewed with caution until more 
specific studies can be done to assess the short term impact of newer 
immunosuppressive regimens and the completion of long term studies to 
assessing the potential for developmental anomalies and delayed toxicity. 
Features of obstetric ARF in two periods 
 Over a period of 16 years (1982-1997) we collected 131 cases of ARF 
in pregnant women. Septic abortion was the sole cause of ARF in early 
pregnancy. In late pregnancy, main causes of ARF were eclampsia and 
puerperal sepsis. However, the overall main cause of obstetric ARF is 
preeclampsia. Acute tubular necrosis (ATN) was the predominant 
histopathologic lesion in pregnancy-related ARF. The overall prevalence of 
renal cortical necrosis was 15 to 25 percent. The incidence of septic abortion 
related ARF has declined from 9.3% in 1982-89, to 7% in 1990-97, of total 
number cases in these periods. Maternal mortality has been also reduced. 
However, overall prevalence of obstetric ARF has not changed much over a 
period of 15 years.  
 
Classification and etiology of obstetric ARF 
 Pregnancy-related ARF in the Indian subcontinent may be classified 
as follows: 
1. ARF in early pregnancy 
2. ARF in late pregnancy 
3. renal cortical necrosis in pregnancy 
4. ARF peculiar to pregnancy 
5. miscellaneous cause of ARF during pregnancy 
ARF in early pregnancy 
 ARF in early pregnancy is almost always due to septic abortion. 
Abortion is only rarely spontaneous; whereas in the vast majority of 
cases (85%) abortion is conducted by self-trained and unauthorized 
personnel under unhygienic conditions. Pregnancy is terminated by the 
insertion of abotifacient chemical (soap, phenol, and quinine), stick, oral 
drugs or a combination of methods. The legalization of abortion in 
France followed by a decrease in the percentage of cases of ARF 
attributable to obstetric causes from 40%in 1978 to 4.5% in 1996. 
Complications of illegal abortion were a major cause of ARF in Rumania 
from 1966 to 1989. From 1990 to 1992, after the legalization of abortion, 
obstetric ARF accounted for only 1.52% of the total cases. In South 
Africa, with improvement obstetric care, the proportion of obstetric ARF 
secondary to septic abortion decreased from 65 percent in 1978 to 19 
percent in 1991.The factors contributing to renal damage associated with 
septic include septicemia, nephrotoxic abortifacients, uterine 
hemorrhage, hypotension intravascular hemolysis, and volume depletion 
from vomiting, and disseminated intravascular coagulation (DIC). 
 ARF can occur in the setting of sepsis from any organism following 
abortion but is most common and most dramatic with infection by 
clostridium welchii, because of its production of toxins which cause 
hemolysis and renal failure. The infection may follow a fulminant course 
characterized by severe abdominal pain and vascular collapse. 
Clostridium welchii is difficult to culture but characteristic gas in the 
uterine wall on X-ray is highly suggestive.  
              
 
 
 
 
 
 
 
The care is supportive, aimed at fluid administration and control of 
infection. The need for hysterectomy has been debated but can be 
avoided with early aggressive conservative treatment. Further more, the 
prevention of unwanted pregnancy and prohibition of illegal abortion are 
keys to eliminate ARF associated with septic abortion in early pregnancy. 
ARF in late pregnancy 
 Obstetric complications such as eclampsia, abruptio placentae, 
intrauterine fetal death, ante/postpartum hemorrhage and puerperal sepsis 
may cause ARF in late pregnancy. Renal hypo perfusion is a major factor 
responsible for ARF in these patients. The DIC and adult HUS may occur 
in association with the puerperal sepsis. Decreased glomerular filtration 
rate and decreased sodium excretion are characteristics of preeclampsia. 
However, frank ARF is unusual, unless complications such as abruptio-
placentae is super imposed on preeclampsia or preeclampsia progresses 
to develop hemolysis with elevated lever enzymes and low platelet count 
(HELLP syndrome). In the largest series of patients with HELLP, only 
7.7% developed. Women who do not have underlying renal disease or 
essential hypertension usually recover if they have ARF secondary to 
preeclampsia when ARF occurs in women with chronic renal disease and 
renal insufficiency, as many as 80 percent eventually become dialysis 
dependent. 
Renal cortical necrosis (RCN) 
 Renal cortical necrosis is an uncommon entity that accounts for only 2 
percent of all causes. The majority of patients with obstetric ARF follow 
a course typical of acute tubular necrosis with recovery. However, 
obstetric complications are the most common causes of renal cortical 
necrosis. Obstetric causes account for RCN in 56 percent and 65.2 
percent of patients reported in two Indian studies. The incidence of renal 
cortical necrosis ranges between 10 and 30 percent of all cases of 
obstetric ARF. The overall incidence of cortical necrosis in obstetric 
ARF was 25 percent in a series. RCN should be suspected in the setting 
of obstetric ARF with a prolonged period of oligoanuria. The oligoanuria 
phase may extend for weeks to months and patients with diffuse cortical 
necrosis may never enter a diuretic phase. The patients with patchy 
cortical necrosis may have partial recovery but may show later 
progression to end-stage renal disease.  
 
 
 
 
 
 The gold standard for establishing the diagnosis is the renal biopsy 
study. Detection of eggshell or cortical tram-track calcification on plain 
x-ray of abdomen is helpful but is seen only in minority of patients. In 
recent years, CT scan has emerged as a good non-invasive modality for 
early diagnosis of renal cortical necrosis.  
                The characteristic finding is the presence of hypo-attenuating 
sub capsular rim of renal cortex following contrast injection. In addition, 
a non-contrast CT scan is more sensitive in picking up the cortical 
calcification. The diagnosis of RCN is made primarily for prognostic 
purposes.  
Acute renal failure peculiar to pregnancy 
There are two uncommon factors peculiar to pregnancy:  
a. ARF in association wit acute fatty lever of pregnancy. 
b. Post partum hemolytic uremic syndrome. 
 
 
 
Acute fatty-lever of pregnancy 
It is an obstetric emergency which, if untreated, may progress to a  
fulminant hepatic failure, a life threatening condition for both the mother 
and fetus. The disease is fortunately rare most often, a patient presents in the 
third trimester with complaints of headache, fatigue, malaise, nausea and 
abdominal pain. Late signs include jaundice, bleeding seizures, hepatic 
encephalotathy. Hyperbilirubinemia (predominantly conjugated); and 
slightly elevated serum transaminase and alkaline phosphatase levels are 
common .Liver biopsy micro vascular fatty infiltration of hepatocytes in a 
centrilobular distribution. The maternal mortality rate for the disease has 
improved from 85 percent in the 1970’s to less than 20 percent in recent 
series, with the lowest mortality rate reported being 6.6 percent. The 
etiology of syndrome is unknown but recent investigations have found the 
familial genetic defect in fatty acid metabolism. 
ARF of some degree occurs in up to 90 percent of patients with acute 
fatty liver of pregnancy and is due to either to a pre renal mechanism or to 
acute tubular necrosis. Renal failure is rarely severe enough to require 
dialysis and death is commonly due to hepatic failure, bleeding or acute 
pancreatitis rather than renal failure. Treatment includes delivery of the baby 
and supportive care. Acute renal failure usually resolves post-partum, as 
does the liver failure. In survivors, no recurrence of acute fatty-liver of 
pregnancy has been observed in the subsequent pregnancies. 
 
Postpartum hemolytic uremic syndrome(HUS)  
 The syndrome of HUS is characterized by a micro-angiopathic 
hemolytic anemia, thrombocytopenia and renal failure. Post-partum HUS 
referred to as idiopathic post partum renal failure in early reports which 
usually occurs between as early as day one and as late as three months post-
partum. It may occur prior to delivery as well (antepartum HUS). The 
pathogenesis of the syndrome is multi factorial but vascular endothelial 
damage appears to be the primary lesion. Familiar occurrence is well known 
and pregnancy associated HUS has been reported in sisters. Renal failure in 
postpartum HUS is often severe requiring temporary dialysis. However, 
some patients develop renal damage and may progress to end-stage. Renal 
diseases requiring chronic dialysis are transplant. 
 It should be noted that renal failure, thrombocytopenia and 
microangiopathic hemolytic anemia may be associated with the other 
gestational complications such as preeclampsia, HELLP syndrome, 
thrombotic thrombocytopenic purpura and antepartum HUS. Sometimes 
there is difficulty in distinguishing HUS from severe preeclampsia 
accompanied by HELLP syndrome. Some distinguishing features include 
isolated elevation of LDH in HUS as opposed to elevation of in 
preeclampsia/HELLP syndrome. Elevation of prothrombin time and partial 
thromboplastin time are unusual in HUS and suggest preeclampsia. 
Preeclampsia generally improves following delivery, although there may be 
transient worsening for 48 hours HUS is not improved by termination of 
pregnancy. This distinction is important, as preeclampsia resolves supportive 
care following delivery, whereas HUS is generally irreversible without 
plasma exchange. 
 Plasma exchange is the mainstay of treatment of HUS and the related 
syndrome such as thrombotic thrombocytopenic perpura. Prior to the advent 
of plasma pheresis the maternal mortality rate was 90 percent. With this 
treatment, maternal survival has increased to 70-80 percent, with the most 
clear-cut efficacy in thrombotic thrombocytopenic purpura. Plasma 
exchange during pregnancy has not shown adverse effects on the fetus.  
 
 
 
 
 
 
 
 
While advances in treatment have dramatically increased patients 
survival in obstetric HUS, it still poses a significant threat to both mother 
and fetus, particularly if not diagnosed and treated promptly. Patients with 
pregnancy associated HUS should be aware of the possibility of recurrence 
in future pregnancies or with estrogen containing oral contraceptives. 
However, at present there is no method to identify those risks. 
Miscellaneous causes of ARF  
 Obstructive ARF has been reported in pregnancies complicated by 
hydramnious or incarcerated gravid uterus, and even in normal pregnancy. 
ARF may develop after amniotic fluid embolism, which occurs primarily in 
multiparas after difficult and prolonged labor. Gravidas with underlying 
renal disease are more apt to ATN especially in the presents of significant 
hypertension or superimposed preeclampsia. Finally, ARF may be caused by 
factors unrelated to pregnancy, such as incompatible blood transfusion, acute 
glomerulonephritis, and endocarditis or drug nephrotoxicity. 
Acute pyelonephritis  
  It is a relatively rare cause of ARF. Renal failure may be precipitated 
or aggravated by the use of nonsteroidal anti-inflammatory drugs or 
potential nephrotoxic antibiotics for example, Amnioglycosides. Early and 
adequate antibiotic therapy, supportive management and closed supervision 
should prevent ARF in gravidas with acute pyelonephritis. 
 Volume contraction   
###Volume contraction is an important cause of ARF in pregnancy. In 
late pregnancy, the causal factor is often blood loss resulting from concealed 
or over uterine hemorrhages, whereas hyperemesis gravidarum and vomiting 
late in gestation or much less common causes. The deleterious effects of 
blood loss are probably maximal in preeclamptic women whose 
intravascular volume is already relatively contracted, who possibly have 
relative prostaglandin deficiency with increased reactivity to 
vasoconstrictive hormones, or in patients with abruptio placentae who show 
severe coagulation disturbances. Early and appropriate restoration of blood 
volume should prevent renal failure. Volume depletion from vomiting and 
sepsis contribute to renal hypo perfusion in patients with septic abortion. 
 
 
 
 
 
 
 
Summary 
Acute renal failure (ARF) in pregnancy constitutes about 15-22 
percent of all cases of ARF referred for dialysis in India. In contrast, ARF is 
a rare complication of pregnancy in developed countries. The majority of 
gravidas (60-70%) develop ARF following septic abortion in India. The 
remaining gravidas (30-40%) develop ARF due to the complications of late 
pregnancy, i.e. Eclampsia, intrauterine fetal death, uterine hemorrhage. 
Pathogenetic factors that predispose to ARF include enhanced vascular 
reactivity to catecholamine and Angiotensin, renal ischemia due to 
hypotensive effect of hemorrhage and severe sepsis, intravascular hemolysis, 
disseminated intravascular coagulation (DIC) and volume contraction. The 
vast majority cases of obstetric ARF show histologically changes of  acute 
tubular necrosis (ATN). However, renal cortical necrosis (RCN) is observed 
in 20-25 percent of cases.  
                    The frequency of RCN in association with septic abortion is 
higher in developing countries as compared to that in the developed ones. 
The disease carries a high maternal mortality. Sepsis and pulmonary 
complications are the major causes of death 
 
 
 
 
 
 
 
  
 
 
  
 
 
 
 
 
 
 
 
                                  
 
 
                      
 
                            Materials and methods 
 
   All patients who were referred to Department of Nephrology with renal 
failure complicating pregnancy between Jan 2006 and Jan 2008 were 
included in this study. Total patients were 52 in number. All of these 
 patients were referred from different parts of Tamilnadu. Most of these 
patients were referred from Department of Obstetrics attached to our college 
and from various District headquarters hospital. Their age ranged between 
20 and 35 years, the mean being 25.5 years.  
Statistical analysis  
          Variables which were analyzed as qualititative data included Age 
group, Place of delivery, antenatal check up, pre existing Hypertension, 
dialysis requirement, duration of dialysis session, birth weight and cause of 
renal failure. Qualititative data are given in frequencies with their 
percentages. Quantitative data are given in mean and standard deviation.  
Quantitative data were analyzed using One way analysis of Variance F – 
test. Correlation between age and other parameters were analyzed using 
Pearson’s correlation coefficient. Incidence of obstetric ARF was given in 
proportion with Fisher 95% confidence interval. P value less than 0.05 were 
taken as significant 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                        Observations  
 
     Most of our patients were between 21-25 years contributing more than 
half of our cases. Patients with Postoperative cause were older, the mean age 
being 31.6 years.  65.6% of them delivered in hospital and remaining 34.6% 
delivered in home. 69.2% had antenatal check ups whereas 30.8% of the 
patients who were referred with renal failure did not have any antenatal 
check up. 23.1% had preexisting hypertension.75% of total patients required 
dialysis. 
    Among the causes of renal failure, Sepsis contributed most of cases 
accounting for 28.8% of cases. PIH stood as second most common cause 
contributing19.2% of total cases.  Other significant causes include 
Preexisting renal diseases, HUS, HELLP, Postoperative causes, Ante partum 
eclampsia, DIC 
    Pregnant patients with renal failure were analyzed based on their place of 
delivery. 73.3% of sepsis related cause was delivered at home. 55.6% of 
patients with preexisting renal diseases delivered at home. Both of patients 
who had DIC in our study had home delivery.  
   13 of 52 patients did not require dialysis which included 50% of PIH, 
26.7% of Sepsis,50% of Ante partum Eclampsia cases 
    Duration of dialysis session was correlated with independent cause of 
renal failure. Three fourth of HELLP and two thirds of Post operative cases 
required less than 5 sessions whereas two thirds of  preexisting renal 
diseases and 50% of PIH  required more than 15 sessions. 
     Correlating birth weight with independent cause of renal failure in our 
patients we found that pre existing renal disease patients delivered babies 
with mean birth weight of 2.21 kg  
     Two thirds of preexisting renal diseases and 60% of PIH cases did not 
have any Antenatal check up. 
      70% of PIH cases and 55.6% of patients with preexisting renal diseases 
had family history of hypertension. 
 
 
 
 
 
 
                                    Discussion 
 
 
Over a period of 16 years (1982-1997), septic abortion was the sole 
cause of ARF in early pregnancy. In late pregnancy, main causes of ARF 
were Eclampsia and puerperal sepsis. The overall prevalence of renal 
cortical necrosis was 15 to 25 percent. The incidence of septic abortion 
related ARF has declined from 9.3% in 1982-89, to 7% in 1990-97, of total 
number cases in these periods. Maternal mortality has also been reduced. 
Acute renal failure (ARF) in pregnancy constitutes about 15-22 percent of 
all cases of ARF referred for dialysis in India. The majority of gravidas (60-
70%) develop ARF following septic abortion in India. The remaining 
gravidas (30-40%) develop ARF due to the complications of late pregnancy, 
i.e. Eclampsia, intrauterine fetal death, uterine hemorrhage 
         Our study which was primarily done as single point study revealed 
sepsis as leading cause. Further it was found that 30.8% of cases did not 
have any antenatal check up.17% of cases had preexisting renal disease 
which was detected for first time during their workup of renal failure. Rising 
incidence of renal disease probably getting reflected by undetected renal 
disease accounting for nearly 17 % of cases 
       Among cases of ARF obstetric causes contributed to 8.8% of total 
number which is more or less in comparison to other countries.  
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
           Cause of renal failure            Percent contribution 
Sepsis                      28 
PIH                      19 
Preexisting renal disease                      17 
HUS                       12 
HELLP                       8 
Postoperative cause                       6 
Ante partum Eclampsia                       4 
DIC                       4 
Hyper emesis Gravidarum                       2 
  
  
Conclusion  
  Pregnancy-related ARF has virtually disappeared from the 
economically advanced countries. This progress is chiefly attributed to 
legalized abortion, consequently, to a decline in septic abortion, and 
improvement in antenatal care. The incidence of severe ARF in pregnancy is 
high in the Indian and septic abortion remains the major cause of ARF. 
Despite legalization of abortion, good number pregnant women seek 
abortion from untrained and unlicensed abortionist under unhygienic 
conditions, probably due to social stigma attached to abortion. In contrast to 
the low rates of cortical necrosis (1.5%). In early pregnancy in western 
countries its incidence remains high (25%) in India.  
 
 
 
 
 
 
 
 
The frequency distribution of ARF in pregnancy is still bimodal in Indian 
subcontinent, where as early peak of ARF in pregnancy has disappeared in 
the developed countries. Thus, ARF in pregnancy is larger in largely 
preventable because it is usually the result of obstetric complication and not 
intrinsic renal disease. With this in mind, pregnancy related acute renal 
failure could be viewed as a public health problem rather than a 
nephrological problem. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
  
  
 
 
 
 
 
Bibiliography 
1. Studd J: The origin and effects of proteinuria in pregnancy. J Obstet 
Gynecol Br Commonwealth 80:872-883,1973 
2. Dieckman WJ: Acute nephritis and pregnancy. Am J Obstet Gynecol 
32:227-240,1936 
3. Lindheimer MD, Katz AI: The Kidney in pregnancy. N Engl J Med 
283: 1095-1097,1970 
4. Packham DK, North RA, Fairly KF, et al: Primary glomerulonephritis 
and pregnancy. QJ Med 266:537-553,1989 
5. Barcelo P,Lopez-Li J, Cabero L, Del Rio G: Successful pregnancy in 
primary glomerular disease. Kidney Int 30:914-919, 1986 
6. Imbasciatti E, Pardi G, Capetta P, et al: Pregnancy in women with 
chronic renal failure. Am J Nephrol 6:193-198,1986 
7. Hou SH, Grossman SD, Madias NE: Pregnancy in women with renal 
disease and moderate renal insufficiency. Am J Med 78:185-194, 
1985 
8. Abe S: Pregnancy in glomerulonephritic patients with deceased renal 
function. Hypertens Pregnancy 15:305-312, 1996 
9. Jungers P, Chauveau D, Choukroun G, et al: Pregnancy in women 
with impared renal function. Clin Nephrol 47:281-288, 1997 
10. Jones DC, Hayslett JP: Outcome of pregnancy in women with 
moderate or severe renal insufficiency. N Eng J Med 335:226-232, 
1996 
11. Cunningham FG, Cox SM, Handstand TW, et al: Pregnancy in 
women with chronic renal failure. Am J Obstet Gynecol 163:453-
459,1990 
12. Leavey SF,Weitzel WF: Endocrine abnormalities in chronic renal 
failure. Endocrinol Metab Clin North Am 31:107-119, 2002 
13. Palmer B: Sexual dysfunction in men and women Semin Dial 10:48-
60, 2003 
14. Lim VM:Reproductive function in patients with renal insufficiency. 
Am J Kidney Dis 9:363-367, 1987 
15. Shemin D: Dialysis in pregnant women with chronic kidney disease. 
Semin Dial 16:379-383, 2003 
16. Hou S: Pregnancy in renal transplant recipients. Adv Ren Replace 
Ther 10:40-47, 2003 
17. Jungers P, Chauveau D: Pregnancy in renal disease. Kidney Int 
52:871-885, 1997 
18. Surian M, Imbasciati E, Cosci P: Glomerular disease and pregnancy: 
A study of 123 pregnancies in patients with primary and secondary 
glomerular diseases. Nephron 36:101,1984 
19. Hou S: Pregnancy in women with chronic renal disease. N Engl J Med 
312:836, 1985 
20. Bar J, Orvieto R, Shalev Y, et al: Pregnancy outcome in women with 
primary renal disease. Isr Med AssocJ 2: 178-181, 2000 
21. Jones DC, Hayslett JP: Outcome of pregnancy in women with 
moderate or severe renal insufficiency. N Engl J Med 335:226, 1996 
22. Mackey EV: Pregnancy and renal disease. Aust N Z J Obstet 
Gynaecol 21:38-45, 1968 
23. Kincaid-Smith P, Fairley Bullen M: Kidney disease and pregnancy. 
Med J Aust 2:1155-1159, 1968 
24. Fink JC, Schwartz SM, Benedetti TJ, et al: Increased risk of adverse 
maternal and infant outcomes among women with renal disease. 
Paediatr Perinat Epidemiol 12: 277-287, 1988 
25. Fischer MJ, Lehnerz SD, Hebert JR, et al: Kidney disease is an 
independent risk factor for adverse fetal and maternal outcomes in 
pregnancy. Am J Kidney dis 43:415-423, 2004 
26. Grunfeld JP, Pertuiset N. Acute renal failure in pregnancy. Am J 
Kidney Dis 1987;9:359-362 
27. Lindheimer MD, Datz AI, Ganeval D et al. Acute renal failure in 
pregnancy. In Brenner BM, Lazarus JM (Eds): Acute renal failure. 
Philadelphia: WB Saunders 1976; 510-526 
28. Chugh KS, Singhal PC, Sharma BK et al. Acute renal failure of 
obstetric origin. Obstet Gynaecol 1976; 48:642-646 
29. Jai Prakash, Singh RG, Tripathi K et al. Acute renal failure in 
pregnancy. Journal of Obst and Gynaecol of India 1985; XXXV; 233-
238 
30. Chugh KS, Sakhuja V, Malhotra HS, Pereira BJ . changing trends in 
acute renal failure in third world countries. Chandigarh Study QJ Med 
1989: 73:1117-1123 
31. Sitprija V, Benyajati C. Tropical diseases and acute renal failure. An 
Acad Med (Singapore) Suppl, 1975;4:112-114 
32.  Jai Prakash, Tripathi K, Usha, Pandey LK, Srivatsava PK. Pregnancy 
related acute renal failure in Eastern India. J Nephrol 1995;8:214-218 
33. Zewdn W. Acute renal failure in Addis Ababa Ethiopia a prospective 
study of 136 patients. Ethiop Med J 1994; 32:79-87 
34. Bangboye El Mabayoje MO, Odutola TA, Mabadeje AF. ARF at the 
Lagos University Teaching Hospital: A 10 Years review. Ren Fail 
1993: 15: 77-80 
35. Grunfeld JP, Ganeval D, Boumerias F: Acute renal failure in 
pregnancy, Kidney Int 1980;18: 179-191 
36. Vladutiu DS, Spanu C, Patiu IM, Neamtu C,  Ghennan M, Manasia 
M. Abortion prohibition and acute renal failure: The tragic Romanian 
experience. Ren Fail 1995;17:605-609 
37. Randeree IG, Czamocki A, Moodley J, Seedat YK, Naiker IP, Acute 
renal failure in pregnancy in South Africa. Ren Fail 1995;17:147-153 
38. Hawkins DF, Sevitt LH, Fairbrother PF, Tothill AU. Management of 
septi abortion with renal failure. Use of conservative regimen. N Engl 
J Med 1975 ;292;722-725. 
39. Krane NK . Acute renal failure in pregnancy: Arch Int Med 1988; 
148:2347-2357. 
40. Jai Prakash, Singh RG,  Tripathi K et al: Adult hemolytic uraemic 
syndrome. Jour Assoc Phy Ind 1986;34:814-815. 
41. Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman 
SA. Maternal mobidity and mortality in 442 pregnancies with 
hemolysis, elevated liver enzymes and low platelets (HELLP 
syndrome). Am J Obstet Gynaecol 1993;169:1000-1006 
42. Jai Prakash,  Tripathi K, Pandey LK, Gadela SR   Usha: Renal cortical 
necrosis in pregnancy related to acute renal failure. J Ind Med Assoc 
1996;94:227-229. 
43. Chugh KS, Jha V, Sakhuja V, Joshi K. Acute renal cortical necrosis- a 
study of 113 patients. Ren Fail 1994; 16:37-47 
44. Jai Prakash,  Tripathi K, Pandey LK et al. Spectrum of renal cortical 
necrosis in ARf in eastern India. Postgrad Med J 1995; 71: 208-210 
45. Kleiknecht  D, Grunfeld JP,  Gomez PC, Moreau JF, Garcia Torres R. 
Diagnostic procedures and long term prognosis in bilateral renal 
cortical necrosis. Kidney Int 1973;4:390-40. 
46. Agarwal A, Sakhuja V, Malik N, Joshi K, Chugh KS: The diagnostic 
value of CT scan in acute renal cortical necrosis. Ren Fail 
1992;14:193-196. 
47. Rmuzzi G, Ruggeneti P. The hemolytic uraemic syndrome. Kidney Int 
1995; 48: 2-19 
48. Conlon PJ, Howell DN, Macik G, Kovalik EC Smith SR. The renal 
manifestations and outcome of thrombotic thrombocytopenic purpura/ 
hemolytic uremic syndrome in adults. Nephrol Dial Transplant 
1995;10: 1183-1193 
49. McCare KR, Cines DB. Thrombotic microangiopathy during 
pregnancy. Semin Hematol 1997;34: 148-158 
50. Ezra Y, Rose M, Eldor A. Therapy of thrombotic thrombocytopenic 
purpura during pregnancy: A clinical study of 16 pregnancies. Am J 
Hematol 1996; 51: 1-6. 
51. Smith K, Borwn JCM, Schackman P, Wrong ON. Renal failure of 
obstetric origin. Br Med Bull 1968;24:49-56. 
 
STATISTICAL ANALYSIS 
 
Qualitative data were given in frequencies with their percentages. 
Quantitative data were given in mean and standard deviation. 
Quantitative data were analyzed using one way Analysis of Variance F-test.  
Correlation between age and other parameters were analyzed using pearson correlation coefficient. 
Incidence of obstetric ARF were given in proportion with Fisher 95% confidence interval 
P value less than 0.05 was taken as significant. 
 
 
 n % 
<= 20 2 3.8%
21 - 25 28 53.8%
26 - 30 16 30.8%
Age group 
31 - 35 6 11.5%
Hospital 34 65.4%Delivered at 
Home 18 34.6%
No 16 30.8%AN_check_up 
Yes 36 69.2%
No 40 76.9%Pre_existing_HT 
Yes 12 23.1%
No 13 25.0%dialysis 
Yes 39 75.0%
<=5 11 21.2%
6 - 10 12 23.1%
11 - 15 10 19.2%
Dialysis_session 
> 15 19 36.5%
<2.5 kg 9 17.3%
2.5 - 3.0 kg 34 65.4%
Birth_ wt 
> 3.0 kg 9 17.3%
PIH 10 19.2%
Sepsis 15 28.8%
HELLP 4 7.7%
Post op 3 5.8%
Pre existing renal 
diseases 9 17.3%
HUS 6 11.5%
Ante partum eclampsia 2 3.8%
DIC 2 3.8%
Diagnosis 
Hyperemesis 
gravidarum 1 1.9%
 
 
 
 
 
 
Age group 
<= 20 21 - 25 26 - 30 31 - 35 
 n % n % n % n % 
PIH   5 50.0% 3 30.0% 2 20.0% 
Sepsis   7 46.7% 6 40.0% 2 13.3% 
HELLP   2 50.0% 2 50.0%    
Post op     1 33.3% 2 66.7% 
Pre existing renal diseases
1 11.1% 7 77.8% 1 11.1%    
HUS   4 66.7% 2 33.3%    
Ante partum eclampsia   2 100.0%      
DIC   1 50.0% 1 50.0%    
Diagnosis 
Hyperemesis gravidarum 1 100.0%        
 
 
 
 
 
Delivered at 
Hospital Home 
 n % n % 
PIH 10 100.0%    
Sepsis 4 26.7% 11 73.3% 
HELLP 4 100.0%    
Post op 3 100.0%    
Pre existing renal 
diseases 4 44.4% 5 55.6% 
HUS 6 100.0%    
Ante partum 
eclampsia 2 100.0%    
DIC   2 100.0% 
Diagnosis 
Hyperemesis 
gravidarum 1 100.0%    
 
 
 
 
 
 
 
 
 
 
 
 
AN_check_up 
No Yes 
 n % n % 
PIH 6 60.0% 4 40.0% 
Sepsis   15 100.0% 
HELLP 2 50.0% 2 50.0% 
Post op   3 100.0% 
Pre existing renal 
diseases 6 66.7% 3 33.3% 
HUS 2 33.3% 4 66.7% 
Ante partum 
eclampsia   2 100.0% 
DIC   2 100.0% 
Diagnosis 
Hyperemesis 
gravidarum   1 100.0% 
 
 
 
 
Family_History_of_HT 
No Yes 
 n % n % 
PIH 3 30.0% 7 70.0% 
Sepsis 15 100.0%    
HELLP 3 75.0% 1 25.0% 
Post op 2 66.7% 1 33.3% 
Pre existing renal 
diseases 4 44.4% 5 55.6% 
HUS 6 100.0%    
Ante partum 
eclampsia 2 100.0%    
DIC 2 100.0%    
Diagnosis 
Hyperemesis 
gravidarum 1 100.0%    
 
 
 
 
 
 
 
 
 
 
 
 
 
Pre_existing_HT 
No Yes 
 n % n % 
PIH 10 100.0%    
Sepsis 12 80.0% 3 20.0% 
HELLP 4 100.0%    
Post op 3 100.0%    
Pre existing renal 
diseases   9 100.0% 
HUS 6 100.0%    
Ante partum 
eclampsia 2 100.0%    
DIC 2 100.0%    
Diagnosis 
Hyperemesis 
gravidarum 1 100.0%    
 
 
 
 
 
 
 
 
dialysis 
No Yes 
 n % n % 
PIH 5 50.0% 5 50.0% 
Sepsis 4 26.7% 11 73.3% 
HELLP   4 100.0% 
Post op   3 100.0% 
Pre existing renal 
diseases 2 22.2% 7 77.8% 
HUS   6 100.0% 
Ante partum 
eclampsia 1 50.0% 1 50.0% 
DIC   2 100.0% 
Diagnosis 
Hyperemesis 
gravidarum 1 100.0%    
 
 
 
 
 
 
 
 
 
Dialysis_session 
<=5 6 - 10 11 - 15 > 15 
 n % n % n % n % 
PIH 4 40.0% 1 10.0%   5 50.0% 
Sepsis 2 13.3% 5 33.3% 4 26.7% 4 26.7% 
HELLP 3 75.0% 1 25.0%      
Post op 2 66.7% 1 33.3%      
Pre existing renal diseases
    2 22.2% 7 77.8% 
HUS   3 50.0% 3 50.0%    
Ante partum eclampsia   1 50.0%   1 50.0% 
DIC     1 50.0% 1 50.0% 
Diagnosis 
Hyperemesis gravidarum       1 100.0% 
 
 
 
 
Birth_ wt 
<2.5 kg 2.5 - 3.0 kg > 3.0 kg 
 n % n % n % 
PIH   10 100.0%   
Sepsis   8 53.3% 7 46.7%
HELLP   4 100.0%   
Post op   1 33.3% 2 66.7%
Pre existing renal diseases
8 88.9% 1 11.1%   
HUS   6 100.0%   
Ante partum eclampsia   2 100.0%   
DIC   2 100.0%   
Diagnosis 
Hyperemesis gravidarum 1 100.0%     
 
 Statistics 
 
  age 
Dialysis_s
ession Birth_ wt 
Mean 25.52 9.46 2.723
Std. Deviation 3.622 4.914 .3551
Minimum 18 3 2.0
Maximum 33 21 3.4
 
 
 
 
 
 Correlations 
 
 Age and other 
parameters 
Dialysis_s
ession Birth_ wt 
Pearson Correlation -.285 .440(**)
Sig. (2-tailed) .079 .001
N 39 52
**  Correlation is significant at the 0.01 level (2-tailed). 
 
Descriptives 
 
age  
  N Mean Std. Deviation 
Oneway 
ANOVA 
PIH 10 26.00 4.320
Sepsis 15 26.60 3.247
HELLP 4 25.50 2.887
Post op 3 31.67 1.528
Pre existing renal diseases 
9 23.44 1.944
HUS 6 24.17 2.563
Ante partum eclampsia 2 22.50 .707
DIC 2 26.00 1.414
Hyperemesis gravidarum 1 18.00 .
Total 52 25.52 3.622
F=3.37 
P=0.004 
significant 
 
  
 
 
 
 
 
 
Dialysis_session  
  N Mean Std. Deviation 
Oneway 
ANOVA 
PIH 5 4.80 .837
Sepsis 11 8.45 3.616
HELLP 4 5.25 1.258
Post op 3 4.33 1.528
Pre existing renal 
diseases 7 16.71 2.059
HUS 6 10.83 2.229
Ante partum eclampsia 1 6.00 .
DIC 2 15.00 1.414
Total 39 9.46 4.914
F=16.39
P=0.001
significant
 
  
 
Birth_ wt  
  N Mean Std. Deviation 
Oneway 
ANOVA 
PIH 10 2.730 .1703
Sepsis 15 3.000 .2726
HELLP 4 2.600 .0816
Post op 3 3.200 .2000
Pre existing renal diseases 
9 2.211 .1833
HUS 6 2.683 .1169
Ante partum eclampsia 2 2.850 .0707
DIC 2 2.750 .0707
Hyperemesis gravidarum 1 2.100 .
Total 52 2.723 .3551
F=14.4 
P=0.001 
significant 
 
 
 
 
 
 
 
Age Distribution
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Std. Dev = 3.62  
Mean = 25.5
N = 52.00
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dialysis_session 
 
  Frequency Percent Valid Percent 
Cumulative 
Percent 
3 1 1.9 2.6 2.6
4 6 11.5 15.4 17.9
5 4 7.7 10.3 28.2
6 6 11.5 15.4 43.6
7 2 3.8 5.1 48.7
8 1 1.9 2.6 51.3
9 1 1.9 2.6 53.8
10 2 3.8 5.1 59.0
12 5 9.6 12.8 71.8
14 3 5.8 7.7 79.5
15 2 3.8 5.1 84.6
16 3 5.8 7.7 92.3
17 2 3.8 5.1 97.4
21 1 1.9 2.6 100.0
Valid 
Total 39 75.0 100.0  
Missing System 13 25.0   
Total 52 100.0   
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